Long-term Follow-up for Multidrug-Resistant Tuberculosis

Shin, Sonya Sunhi; Furin, Jennifer J.; Alcántara, Felix; Bayona, Jaime; Sánchez, Epifanio; Mitnick, Carole Diane

View/Open

3294679.pdf (28.70Kb)

Author

Shin, Sonya Sunhi HARVARD

Furin, Jennifer J. HARVARD

Alcántara, Felix

Bayona, Jaime HARVARD

Sánchez, Epifanio

Mitnick, Carole Diane HARVARD

Published Version

https://doi.org/10.3201/eid1204.041256

Metadata

Show full item record

Citation

Shin, Sonya S., Jennifer J. Furin, Felix Alcántara, Jaime Bayona, Epifanio Sánchez, and Carole D. Mitnick. 2006. Long-term follow-up for multidrug-resistant tuberculosis. Emerging Infectious Diseases 12(4): 687-688.

Abstract

Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.

Other Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294679/pdf/

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA

Citable link to this page

http://nrs.harvard.edu/urn-3:HUL.InstRepos:10121003

Collections

HMS Scholarly Articles [17714]

Contact administrator regarding this item (to report mistakes or request changes)